Vikram Thermo (India) Limited
BBSE:VIKRAMTH336.10
INR
-15.40
(-4.38%)
ISIN
INE337E01010
Return %
Stock
S&P 500
1Y
102.04
14.20
3Y
208.07
81.12
5Y
860.29
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Dhirajlal Karsandas Patel
- Full Time Employees
- 153
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- A/704-714, The Capital Ahmedabad GU India 380060
- IPO Date
- Mar 20, 1995
- Website
- vikramthermo.com
- Similar Companies
- Business
- Vikram Thermo (India) Limited is a pharmaceutical and specialty polymer manufacturing company headquartered in Ahmedabad, India, founded in 1985. The company specializes in the development, manufacture, and marketing of pharmaceutical excipients, coating systems, and specialty polymers primarily for the pharmaceutical and cosmetic industries. Its core product portfolio includes Methacrylic acid-based copolymers under the DRUGCOAT brand, ready-to-use film coating systems under the DRCOAT brand, enteric coatings, moisture barrier coatings, sustained release formulations, and synthetic polymers used as thickening and gelling agents (notably AQUAPOL) for cosmetic applications including hand sanitizers, hair gels, and hand wash products. In addition to pharmaceutical coatings, Vikram Thermo produces Diphenyl Oxide (DPO), an aromatic chemical used in various industrial applications. The company operates two state-of-the-art manufacturing facilities dedicated separately to chemical production and pharma/cosmetic polymers, ensuring compliance with GMP, ISO 9001, and EXCiPACT standards. Recent major changes include the successful completion of a spin-off of its Vikram Aroma Limited subsidiary in June 2024, which allowed a focused realignment of its business interests. The company has expanded its innovation capabilities with the launch of a new dedicated R&D facility in 2025 aimed at advancing pharmaceutical coating technologies. It continues to strengthen its market position with strategic operational improvements and has maintained a rigorous focus on regulatory compliance and quality control to cater to both domestic and international pharmaceutical companies. Vikram Thermo services an expanding geographic footprint primarily across India, with ambitions for international market penetration bolstered by custom product solutions and responsive service tailored to pharmaceutical manufacturers. The company’s business strategy emphasizes capacity expansion, innovation in specialty coatings, and diversification into cosmetic polymers while sustaining its core pharma polymer market leadership. Vikram Thermo operates under a listed public company structure on the Bombay Stock Exchange (Ticker: VIKRAMTH.BO) and engages in sectors including pharmaceutical manufacturing, specialty chemicals, and cosmetic formulation excipients. It targets pharmaceutical companies producing oral solid dosage drugs, generic and branded formulations, and cosmetic manufacturers seeking advanced polymer solutions. The company’s competitive strengths lie in its specialization, product quality, customization capabilities, and compliance adherence, positioning it as a leading domestic player in India’s pharmaceutical excipient and polymer market. Recent governance and management updates, including reappointment of key executives and audit appointments in 2025, demonstrate continued corporate stability and operational governance enhancements.